Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate

As a bisphosphonate, minodronate (MIN) is one of the strongest inhibitors of bone resorption. However, there have been no reports directly comparing the antiresorptive effects of monthly MIN with those of monthly risedronate (RIS). We enrolled 30 cases of osteoporosis (OP; 16 in the MIN group [mean...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamimura, Mikio, Nakamura, Yukio, Ikegami, Shota, Komatsu, Masatoshi, Uchiyama, Shigeharu, Kato, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Osteoporosis 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372746/
https://www.ncbi.nlm.nih.gov/pubmed/30775483
http://dx.doi.org/10.1016/j.afos.2016.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372746/
https://www.ncbi.nlm.nih.gov/pubmed/30775483
http://dx.doi.org/10.1016/j.afos.2016.07.002

Ejemplares similares